Biotech Playbook Revisited As Technicals Weaken…Update-3
Update-3 10/1 10:35a ...Merck Oral COVID Drug disrupts markets.MRK up 9% vaccine stocks down. IBB down 3.2% to $156 handle. Update-3 (continued at 10/1 close) Merck oral COVID drug leads rally with all major Indices up, Dow Up 1.43%, S&P 500 up 1.15%, NAZ up 0.82%. A sense of optimism about...
Biotech and Healthcare Portfolio 2021 as of 9/17…Update-3
Update 3...IBB teetering along SEP Support of $170: 9/24..A lot of red today XBI down 2%. Large caps down as well. BNTX down over 5%. Update-2 Another good day for life science stocks. Still expecting a Q4 biotech bounce in small/mid-cap stocks. FED Meeting supports bullish outlook on the...
Look for the Q4 Biotech Bounce in Mid-Small Caps…Update-1
Biotech Bounce in Mid-Small Caps- life science stocks find buyers. Bellwether tickers : ARKG up 3% to $83.93, XBI up 1.44% to $132.88. Update-1 ...Triple witching selling pressure again as expected but a little green at the end of day. DJI down 0.48%, NASDAQ down 0.91%, S&P 500 down 0.91%....
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market…Update-1
Update-1 Five days of selling but looks like routine re-balancing at market highs. NASDAQ leads way down 0.7% Whether it is concerns about Washington or a seasonal buyers strike or even an extended summer vacation who knows? The 3.3% drop in AAPL on App Store ruling did not help. Here are some...
What’s Next for Biotech Stocks? …Update-1
Update-1 3:45P 9/1 FDA issues warning on JAK Inhibitor drug class. ABBV down 7%., PFE and LLY drugs also affected. Small cap rally intact: CRSP,CYRX, VCYT. Quidel (QDEL) up 5.45% on need for more COVID tests. ARKG and XBI up about 1.5%. Mid-caps all green. IBB up 0.96%. Barron's bullish on...